The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
CHARLOTTE, N.C., March 24, 2021 /PRNewswire/ -- A subsidiary of Duke Energy (NYSE: DUK), Progress Energy, today announced it will direct the trustee for its Contingent Value Obligations to pay holders ...
TAMPA, Fla., Dec. 15, 2025 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to ...
Mirati Therapeutics is a biotech company specializing in oncology therapies, with its star product being adagrasib for treating lung cancer. Bristol Myers Squibb is set to acquire Mirati Therapeutics ...
Quantum BioPharma Ltd. announced its plan to issue a special dividend in the form of Contingent Value Rights (CVRs) to holders of its Class B Subordinate Voting Shares, on a 1:1 basis. Each CVR will ...
Painful sell-off in BMY.RT yesterday after a confusing Bristol-Myers conference call. The call was really awful because BMY basically said two facilities need to be inspected, one isn't and they ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback